SXI Life Sciences
6.963,36
PKT
-12,54
PKT
-0,18
%
Werbung
Analysen zu SXI Life Sciences-Werten
Datum | Rating | Analyst | |
---|---|---|---|
23.09.20 | Novartis Underweight | Barclays Capital | |
23.09.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
22.09.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
21.09.20 | Roche overweight | JP Morgan Chase & Co. | |
18.09.20 | Roche buy | UBS AG | |
15.09.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
15.09.20 | Roche overweight | JP Morgan Chase & Co. | |
14.09.20 | Roche overweight | JP Morgan Chase & Co. | |
10.09.20 | Novartis buy | UBS AG | |
04.09.20 | Roche overweight | JP Morgan Chase & Co. | |
02.09.20 | Roche buy | UBS AG | |
02.09.20 | Roche overweight | JP Morgan Chase & Co. | |
01.09.20 | Novartis overweight | Morgan Stanley | |
26.08.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
21.08.20 | Novartis Neutral | UBS AG | |
21.08.20 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
18.08.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
18.08.20 | Novartis Underweight | JP Morgan Chase & Co. | |
12.08.20 | Novartis Underweight | JP Morgan Chase & Co. | |
11.08.20 | Roche buy | UBS AG | |
10.08.20 | Roche overweight | JP Morgan Chase & Co. | |
10.08.20 | Roche overweight | Morgan Stanley | |
10.08.20 | Roche overweight | Barclays Capital | |
10.08.20 | Roche Outperform | Bernstein Research | |
10.08.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
03.08.20 | Roche overweight | JP Morgan Chase & Co. | |
30.07.20 | Roche buy | UBS AG | |
29.07.20 | Roche Neutral | Credit Suisse Group | |
29.07.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
28.07.20 | Roche overweight | Morgan Stanley | |
28.07.20 | Novartis neutral | Morgan Stanley | |
27.07.20 | Roche buy | UBS AG | |
24.07.20 | Roche overweight | Barclays Capital | |
24.07.20 | Roche Neutral | Credit Suisse Group | |
24.07.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
23.07.20 | Roche buy | UBS AG | |
23.07.20 | Roche overweight | JP Morgan Chase & Co. | |
23.07.20 | Roche overweight | Barclays Capital | |
23.07.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
22.07.20 | Roche overweight | JP Morgan Chase & Co. |